The Somatic Genomic Landscape of Glioblastoma

Brennan, Cameron W., Verhaak, Roel G.W., McKenna, Aaron, Campos, Benito, Noushmehr, Houtan, Salama, Sofie R., Zheng, Siyuan, Chakravarty, Debyani +292 more·2013·Cell

Cited by (1,018)

Items 1,001–1,018 of 1,018

  1. Radiogenomics for Precision Medicine With a Big Data Analytics Perspective
    Panayides, Andreas S., Pattichis, Marios S., Leandrou, Stephanos, Pitris, Costas, Constantinidou, Anastasia, Pattichis, Constantinos S. · 2019 · IEEE Journal of Biomedical and Health Informatics
  2. T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
    Wang, Zhan, Li, Binghao, Ren, Yingqing, Ye, Zhaoming · 2016 · Frontiers in Immunology
  3. Comprehensive pharmacogenomic characterization of gastric cancer
    Sa, Jason K., Hong, Jung Yong, Lee, In-Kyoung, Kim, Ju-sun, Sim, Moon-Hee, Kim, Ha Jung, An, Ji Yeong, Sohn, Tae Sung, Lee, Joon Ho, Bae, Jae Moon et al. · 2020 · Genome Medicine
  4. Biologically interpretable multi-task deep learning pipeline predicts molecular alterations, grade, and prognosis in glioma patients
    Wu, Xuewei, Zhang, Shuaitong, Zhang, Zhenyu, He, Zicong, Xu, Zexin, Wang, Weiwei, Jin, Zhe, You, Jingjing, Guo, Yang, Zhang, Lu et al. · 2024 · npj Precision Oncology
  5. GO-PCA: An Unsupervised Method to Explore Gene Expression Data Using Prior Knowledge
    Wagner, Florian · 2015 · PLOS ONE
  6. Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice
    Bakas, Spyridon, Vollmuth, Philipp, Galldiks, Norbert, Booth, Thomas C, Aerts, Hugo J W L, Bi, Wenya Linda, Wiestler, Benedikt, Tiwari, Pallavi, Pati, Sarthak, Baid, Ujjwal et al. · 2024 · The Lancet Oncology
  7. Immunotherapy Resistance in Glioblastoma
    Wang, Elaina J., Chen, Jia-Shu, Jain, Saket, Morshed, Ramin A., Haddad, Alexander F., Gill, Sabraj, Beniwal, Angad S., Aghi, Manish K. · 2021 · Frontiers in Genetics
  8. Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
    Au, Trang H., Willis, Connor, Reblin, Maija, Peters, Katherine B., Nghiemphu, Phioanh Leia, Taylor, Jennie W., Colman, Howard, Cohen, Adam L., Ormond, D. Ryan, Chakravarti, Arnab et al. · 2022 · Supportive Care in Cancer
  9. A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number
    Lyons, Jonathan J., Stotz, Stephanie C., Chovanec, Jack, Liu, Yihui, Lewis, Katie L., Nelson, Celeste, DiMaggio, Thomas, Jones, Nina, Stone, Kelly D., Sung, Heejong et al. · 2018 · Genetics in Medicine
  10. Immunotherapy in Glioblastoma: A Clinical Perspective
    Desbaillets, Nicolas, Hottinger, Andreas Felix · 2021 · Cancers
  11. Computed cancer interactome explains the effects of somatic mutations in cancers
    Zhang, Jing, Pei, Jimin, Durham, Jesse, Bos, Tasia, Cong, Qian · 2022 · Protein Science
  12. MDM2 inhibition in the treatment of glioblastoma: From concept to clinical investigation
    Pellot Ortiz, Karolina I., Rechberger, Julian S., Nonnenbroich, Leo F., Daniels, David J., Sarkaria, Jann N. · 2023 · Biomedicines
  13. Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2
    Zhang, Ruo-Yu, Yu, Zhi-Hong, Chen, Lan, Walls, Chad D., Zhang, Sheng, Wu, Li, Zhang, Zhong-Yin · 2020 · Journal of Biological Chemistry
  14. Detecting molecular subtypes from multi-omics datasets using SUMO
    Sienkiewicz, Karolina, Chen, Jinyu, Chatrath, Ajay, Lawson, John T., Sheffield, Nathan C., Zhang, Louxin, Ratan, Aakrosh · 2022 · Cell Reports Methods
  15. MiR-128-3p – a gray eminence of the human central nervous system
    Kiel, Klaudia, Król, Sylwia Katarzyna, Bronisz, Agnieszka, Godlewski, Jakub · 2024 · Molecular Therapy Nucleic Acids
  16. Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling
    Oh, Hwanhee, Hwang, Inah, Jang, Ja-Young, Wu, Lingxiang, Cao, Dongqing, Yao, Jun, Ying, Haoqiang, Li, Jian Yi, Yao, Yu, Hu, Baoli et al. · 2021 · Cancer Research
  17. Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma
    Vaubel, Rachael A., Zhang, Wenjuan, Oh, Ju-Hee, Mladek, Ann C., Pasa, Tugce I., Gantchev, Jennifer K., Waller, Katie L., Baquer, Gerard, Stopka, Sylwia A., Regan, Michael S. et al. · 2025 · Clinical Cancer Research
  18. Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts
    Vaubel, Rachael A, Zhang, Wenjuan, Karbhari, Nishika, Oh, Ju-Hee, Waller, Katie L, Mladek, Ann, Jain, Sonia, Burgenske, Danielle M, Decker, Paul A, Kosel, Matt L et al. · 2026 · Neuro-Oncology Advances